Cite
HARVARD Citation
Schwarz, T. et al. (2022). Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women. Journal of infectious diseases. pp. 2067-2076. [Online].